Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study
Alexandra J. Borst(University of North Carolina at Chapel Hill), Michael Jeng(Palo Alto University), Yimei Li(Children's Hospital of Philadelphia), Denise M. Adams(Children's Hospital of Philadelphia), Rachael Schulte(Riley Hospital for Children), Shelley E. Crary(Arkansas Children's Hospital), Stefanos Intzes(Providence Sacred Heart Medical Center), Elissa Engel(Cincinnati Children's Hospital Medical Center), Zili Zong(Children's Hospital of Philadelphia), Jillian S. Dayneka(Children's Hospital of Philadelphia), Whitney Eng(University of Washington), Allison P. Wheeler(Vanderbilt University Medical Center), Steven M. Andreoli(University of Florida), Taizo A. Nakano(Children's Hospital Colorado), Kenneth Heym(Cook Children's Medical Center), Kiersten Ricci(Cincinnati Children's Hospital Medical Center), Morgan Griffin(Harvard University), Bhuvana A. Setty(Nationwide Children's Hospital), Kristy S. Pahl(Duke University), Thomas W. McLean(Atrium Health Wake Forest Baptist), Max Teitelbaum(Morristown High School), Sally Cohen‐Cutler(Children's Hospital of Los Angeles), Melinda Wu(Oregon Health & Science University), Irina Pateva(Rainbow Babies & Children's Hospital)
Cited by 26
Related Papers
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
Kaposiform lymphangiomatosis effectively treated with MEK inhibition
|EMBO Molecular Medicine|2020|104
Genomic profiling informs diagnoses and treatment in vascular anomalies
|Nature Medicine|2023|63
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52